Revatio Special Investigation for Long-term Use in Pediatric Patients

Clinical trial NCT03364244 · COMPLETED

Trial details

NCT number: NCT03364244
Sponsor: Viatris Pharmaceuticals Japan Inc
Status: COMPLETED
Study type: OBSERVATIONAL

Pulmonary Arterial Hypertension

Start date: 2017-11-30
Primary completion: 2022-08-30
Enrollment: 1023

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.